Combretastatin A4

Catalog No. A12601

Combretastatin A4是在体内和体外的抗肿瘤,抗血管生成和抗转移药。Combretastatin A4是一种微管靶向剂,可与β-微管蛋白结合,Kd为0.4μM。
Catalog Num A12601
M. Wt 316.35
Formula C18H20O5
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 117048-59-6
Synonyms CRC 87-09, NSC 817373
SMILES COC1=C(C=C(C=C1)/C=C\C2=CC(=C(C(=C2)OC)OC)OC)O
Combretastatin A4是在体内和体外的抗肿瘤,抗血管生成和抗转移药。Combretastatin A4是一种微管靶向剂,可与β-微管蛋白结合,Kd为0.4μM。
In vitro (25°C) DMSO 58 mg/mL (183.34 mM)
Water Insoluble
Ethanol Warmed: 31 mg/mL (97.99 mM)
In vivo 5% DMSO+50% PEG 300+ddH2O 28 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 31.61 mL 158.05 mL 316.11 mL
0.5 mM 6.32 mL 31.61 mL 63.22 mL
1 mM 3.16 mL 15.81 mL 31.61 mL
5 mM 0.63 mL 3.16 mL 6.32 mL

*The above data is based on the productmolecular weight 316.35. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.